General MedicationsORAL-28Generic

PREMPRO (PREMARIN;CYCRIN)

ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE

Standard Dose

0.625MG,0.625MG;2.5MG,2.5MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Discontinued

Summary

Approval overview PREMPRO (PREMARIN;CYCRIN) is listed in Drugs@FDA under application 020303 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE Form and strength TABLET;ORAL-28 - 0.625MG,0.625MG;2.5MG,2.5MG Sponsor WYETH PHARMS INC Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREMPRO (PREMARIN;CYCRIN) is listed in Drugs@FDA under application 020303 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE Form and strength TABLET;ORAL-28 - 0.625MG,0.625MG;2.5MG,2.5MG Sponsor WYETH PHARMS INC Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.